Press releases
Kelly McGrail-Pokuta joins Prime Therapeutics as vice president, pharmacy trade relations
McGrail-Pokuta brings to Prime more than 25 years of combined experience in the healthcare and pharmaceutical industries
August 13, 2019McGrail-Pokuta will oversee the strategic direction and management of all pharmaceutical manufacturer relationships in support of Prime’s Total Drug Management business model.
McGrail-Pokuta brings to Prime more than 25 years of combined experience in the healthcare and pharmaceutical industries. She has held leadership positions within OptumRx and Diplomat Pharmacy, plus program and product management positions with then CVS Caremark and pharmaceutical companies. Most recently she worked as a consultant in the pharmacy benefit management and pharmacy space.
“Kelly is a seasoned expert in managing the broad continuum of pharmaceutical manufacturer relationships necessary to drive innovative and successful outcomes in a rapidly changing environment” said Jarrod Henshaw, senior vice president, chief supply chain and industry relations officer for Prime. “Her broad experience will help us deliver on our total drug management commitment to our plans and our members, and we are thrilled to have her leading our trade relations efforts.”
McGrail-Pokuta holds a Doctor of Pharmacy degree from the University of Illinois at Chicago and completed her clinical pharmacy practice residency at the University of Illinois Hospital and Clinics.
Related news
Press releases
September 21, 2023
Prime Therapeutics Appoints New Chief Compliance Officer
EAGAN, Minn. – Prime Therapeutics LLC/Magellan Rx, a pharmacy benefit manager (PBM) serving…
Press releases
September 18, 2023
Prime Therapeutics and Magellan Rx enhance specialty pharmacy patient experience with Inovalon’s ScriptMed® SaaS Solution
Eagan, Minn. and Bowie, Md. – Sept. 18, 2023 – Prime Therapeutics LLC…
Press releases
August 28, 2023
Magellan Rx Pharmacy LLC earns URAC Reaccreditation
EAGAN, Minn. – Prime Therapeutics LLC (Prime)/Magellan Rx (MRx) is proud to announce…